Compare FTHY & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTHY | USNA |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 397.1M |
| IPO Year | N/A | 1996 |
| Metric | FTHY | USNA |
|---|---|---|
| Price | $13.61 | $22.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 78.2K | ★ 80.2K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $1,060,902,000.00 |
| Revenue This Year | N/A | $3.90 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | ★ N/A | $54.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.20 | $16.60 |
| 52 Week High | $14.84 | $32.32 |
| Indicator | FTHY | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 52.37 |
| Support Level | $13.40 | $20.50 |
| Resistance Level | $13.76 | $22.75 |
| Average True Range (ATR) | 0.10 | 0.99 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 50.40 | 44.34 |
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).